Crohn Disease : from gene to therapy

Slides:



Advertisements
Similar presentations
Pathogenesis of Antiphospholipid Antibodies in Pregnancy.
Advertisements

Immune Activation/Inflammation and HIV Disease Prof. Georg Behrens Department for Clinical Immunology and Rheumatology Hannover Medical School Germany.
The Microbiome: What’s the immune system got to do with it?
Immunity to microbes (mechanisms of defense against
Immunodeficiencies Complicated by IBD: The Very Young Patient Ted Denson, MD Schubert-Martin Pediatric Inflammatory Bowel Disease Center.
Therapy of Inflammatory Bowel Diseases 2013 Gastroenterology Department Division of Medicine Eran Israeli MD.
Malaria-Induced NLRP12/NLRP3-Dependent Caspase-1 Activation Mediates Inflammation and Hypersensitivity to Bacterial Superinfection Rachel Sippy February.
T cells Jan Novák. The immune system Protection against infectious agents Clearance of dying, damaged and dangerous cells Regulation of the immune responses.
Ulcerative Colitis - before and after Hurst
DRUG TREATMENT OF INFLAMMATORY BOWEL DISEASE. Objectives Describe the mechanism of action, pharmacokinetics and adverse effects of drugs in IBD.
Hannover Medical School February 15 th 2010 The gut microbiota shapes intestinal immune response during health and disease Round and Mazmanian, Nature.
Evaluation of the genetic impact on inflammatory bowel disease Natalie Bibb Trainee Project KGC.
Inflammatory Bowel Disease Treatment. Epidemiology Clinical Laboratory Imaging Pathology Response to treatment IBD.
Immunotolerance Christoph Mueller
HOW TO CONTROL CANCER Putting Science into Practice.
APS 2006 Refresher Course Common auto-immune signaling defects; what does gender have to do with it? Denise Faustman, M.D., Ph.D. Director, Immunobiology.
DAREDEVILS: Prajwal Acharya, Cristina Johnson, Julie David, Jen Masciovecchio, Yen Phan.
Microbiology Pre-AP Introduction to Medical Microbiology.
A new antivirulence approach against pathogenic bacteria A new antivirulence approach against pathogenic bacteria May 2005 Sonia Escaich - President &
DIAGNOSTIC IMMUNOLOGY
Inflammatory Bowel Disease Francisco A. Sylvester, MD Associate Professor of Pediatrics.
Aetiology and Pathology of Inflammatory Bowel Disease. Dr Bryan F Warren Consultant Gastrointestinal Pathologist, John Radcliffe Hospital, Oxford, UK M62.
Musketeers Course October The Mucosal Immune System The organization of the mucosal immune systemThe organization of the mucosal immune system The.
Vedolizumab in Pediatric IBD: We are Ready to Use It
Modeling Crohn’s Disease. Crohn’s disease usually presents in early adulthood. Patients have a markedly reduced quality of life and a 5 to 7-fold increased.
The life history of T lymphocytes Precursors mature in the thymus Naïve CD4+ and CD8+ T cells enter the circulation Naïve T cells circulate through lymph.
Crohn’s Disease & Mycobacterial Infections Kimberly Persley, MD October 19, 2005.
Disease Introduction. Causes Incorrectly functioning organ, structure, or system of the body resulting from genetic errors, infection, poisons, nutritional.
“Deciphering the Dynamic Coupling of the Human Immune System and the Gut Microbiome” Overview Data-Enabled Life Sciences Research (DELSA) DELSA Workshop.
Immune System SC.912.L Explain the basic functions of the human immune system, including specific and nonspecific immune response, vaccines, and.
Beginning of the chapter Crohn's disease and genetics (IBD Sensor) 49.
Immunological Disease of the Gastrointestinal Tract
Principals of Biomedical Research Guri Tzivion, PhD Extension 506 PBMR 611: Winter 2016 Windsor University School of Medicine.
1 Detecting & Responding 2 Unit 3 Biology Area of Study 2.
Effector T Cell Subsets, Cytokines
Environmental factors Dysregulated immune response
GI Pathophysiology Jaeyoung Chun, M.D. Pathophysiology
Learning Objectives Describe the relationship between the JAK-STAT signaling pathway and pathogenesis of inflammatory bowel disease. Summarize the latest.
Modulation of Gene Expression via Disruption Of NF-kB Signaling by a
Ulcerative colitis andTrichuris infection
What’s All the Fuss About the Microbiome?
A Clinical-Translator’s Point-of-View:
The inflammasome of activated human B-cells regulates IL-1β and IgM: A crosstalk between the innate and the adaptive immune response Eva M Carmona MD,
Inflamm Intest Dis 2016;1: DOI: /
Normal Intestine vs. IBD Intestine
Regulatory T cells & parasites: therapeutic potential
A new antivirulence approach against pathogenic bacteria
Innate Immunity.
Microbial Influences in Inflammatory Bowel Diseases
Gut Microbiota: Mining for Therapeutic Potential
Metagenomics and Personalized Medicine
Benoit Chassaing, Arlette Darfeuille–Michaud  Gastroenterology 
Figure 3 Hypothetical mechanisms of smoking-associated
R. Balfour Sartor, MD  Clinical Gastroenterology and Hepatology 
Pathogenic Escherichia coli in inflammatory bowel diseases
The mechanisms for the origin and proliferation of MDR strains.
Role of the dual interaction of fungal pathogens with pattern recognition receptors in the activation and modulation of host defence  M.G. Netea, J.W.M.
IMMUNE RESPONSE TO MYCOBACTERIAL INFECTION
D'oh! Genes and Environment Cause Crohn's Disease
Nod2 in Normal and Abnormal Intestinal Immune Function
Advances and Perspectives in the Genetics of Inflammatory Bowel Diseases  Mathias Chamaillard, Razvan Iacob, Pierre Desreumaux, Jean–Frederic Colombel 
Week 15 Vocab Definitions
Lecture 12 Gastrointestinal Disorders Inflammatory Bowel Disease
Translating Inflammatory Bowel Disease Research into Clinical Medicine
Pathogenesis of IBD, and the Role of Biologic Therapies
Immune reconstitution inflammatory syndrome (IRIS) associated with Mycobacterium tuberculosis (TB) infection. a) In healthy individuals in response to.
Metagenomics and Personalized Medicine
NOD2 and Crohn’s Disease: Loss or Gain of Function?
Genetic Factors and the Intestinal Microbiome Guide Development of Microbe-Based Therapies for Inflammatory Bowel Diseases  Louis J. Cohen, Judy H. Cho,
Presentation transcript:

Crohn Disease : from gene to therapy Prof Jean-Pierre Hugot Hopital Robert Debré Paris, France Jean-pierre.hugot@rdb.aphp.fr

Gordon Oppenheimer, Burill B Crohn and Leon Ginzburg, 1969 From « BB Crohn, Life and Work », Falk Foundation 2000

Treatments for Crohn Disease Antibiotics Probiotics Nutritional support 5 amino-salicylates Steroids Immunosupressive drugs Antibodies against TNF and other chemiokines (IL12, ICAM, a4integrins) Pig parasites Trichuris Suis

Environnemental factor Genetic factor

Bouma G et al. Nature Rev Immunol 2003

IBD loci IBD3 DLG5 IBD7 IBD2 SLC22A4/5 IBD8 IBD6 IBD4 CARD15 1 2 3 4 5 6 7 8 9 10 11 12 IBD8 IBD6 IBD4 CARD15 13 14 15 16 17 18 19 20 21 22 Y X

Bacterial recognition Ibd1-Nod2-Card15 N ter C ter LRR TM ? NBD CARD 1 CARD 2 1 121 129 217 270 299 570 744 1020 1040 NF-kB Activation Oligomerisation Bacterial recognition

Why to discover genes? To make a diagnosis Before disease occurrence (if prevention possible) or to avoid invasive procedures (sensibiility, sensitivity).

Proportion of mutated patients (all non conservative variations *) *except P268S

Why to discover genes? To make a diagnosis Before disease occurrence (if prevention possible) or to avoid invasive procedures (sensibiility, sensitivity). To classify the disease (definition of disease subgoups)

NOD2/CARD15 mutations are associated with : A younger age of onset A more frequent ileal involvement An higher complication rate Lesage et al. Am J Hum Genet 2002 Vermeire et al. Am J Hum Genet 2002 Cuthbert et al. Gastroenterology 2002 Hampe et al. Lancet 2002 Amhad et al. Gastroenterology 2002 Abreu et al. Gastroenterology 2002 Louis E et al. Gut 2003

Why to discover genes? To make a diagnosis To develop a treatment Before disease occurrence (if prevention possible) or to avoid invasive procedures (sensibiility, sensitivity). To classify the disease (definition of disease subgoups) To develop a treatment Gene therapy (in the future?) Pharmacogenetics

Genotype/phenotype relationship : response to Infliximab. Vermeire S et al. Gastroenterology in press

Why to discover genes? To make a diagnosis To develop a treatment Before disease occurrence (if prevention possible) or to avoid invasive procedures (sensibiility, sensitivity). To classify the disease (definition of disease subgoups) To develop a treatment Gene therapy (in the future?) Pharmacogenetics Drug discovery (disease mechanisms)

From Elson C. N Eng J Med 2002

From Ogura et al. Nature 2001

How a defect in a proinflammatory molecule… ..can induce an inflammation?

CARD15 -/- mouse +/+ -/- Pauleau AL et al. Mol Cel Biol 2003

Interaction between TLR2 and NOD2 Watanabe T Nat Immunol 2004

How CD mutations induce the inflammation? A defect in the innate immunity induces an excess of response by the adaptive immunity which is deleterious for the mucosa. CD mutations are gain of fonction mutations (Maeda S Science 2005) CD mutations do not inhibit pro-inflammatoy pathways (Watanabe T Nature Immunol 2004; Chen CM J Biol Chem 2004) CD mutations no more activate anti-inflammatory pathways (IL10) (Netea MG Eur J Immunol 2004)

Unpublished 

CARD15 immunohistochemistry normal colon Crohn Berrebi D et al. Gut 2003 11

Card15 immunohistochemistry Berrebi D et al. Gut 2003

NOD2 and Paneth cells Card15 Lysozyme Crohn normal ileum Ogura Y et al. Gut 2003

Screening for Card15/Nod2 interacting small molecules Loss or gain of function? Which cell line? Role of MDP? Toward a specific curative thérapy?

Why to discover genes? To make a diagnosis To develop a treatment Before disease occurrence (if prevention possible) or to avoid invasive procedures (sensibiility, sensitivity). To classify the disease (definition of disease subgoups) To develop a treatment Gene therapy (in the future?) Pharmacogenetics Drug discovery (disease mechanisms) Prevention (environmental factors)

From Rose J et al. Gut 1988

ENVIRONMENTAL FACTORS FOR CD Tobacco Refined sugars Fast-food and Cola Microparticles Tooth paste Chewing-Gum Margarin Fibres Backer yeast Alcohol Caffe Corn-flakes Curry Hot water Refrigeration Perinatal Infections Infections in childhood Antibiotics Adenoïdectomy Breast feeding Life events Oral contraceptives

Commensal flora…. Or specific pathogenic bacteria ?

Most popular infectious agents for CD Mycobacterium paratuberculosis E coli, Y enterocolitica L monocytogenes Pseudomonas species

way of life Flora? Dlg5? Specific bacteria? Octn 1/2? Card15